Insulin Delivery System Market Trends, Challenges and Opportunities
FAQ's
Answer : The global genomics market size was valued at USD 20.06 billion in 2020 and is expected to hit over USD 72.13 billion by 2030.
Answer : The global genomics market is growing at a noteworthy CAGR of 13.65% from forecast period 2021 to 2030.
Answer : North America holds major importance in the genomics sector and seized more than 45% of the market share in the year 2020.
Answer : Some of the key players operating in the genomics market are F. Hoffmann-La Roche Ltd..; 23andMe,Agilent Technologies, Inc.; Bio-Rad Laboratories, Inc.; Inc.; Illumina, Inc.; Myriad Genetics, Inc.; Thermo Fisher Scientific,Foundation Medicine, Inc.; Danaher; Pacific Biosciences; Oxford Nanopore Technologies; and BGI.
Answer : Market growth is driven by factors such as growing government funding and growth in the number of genomics projects, decreasing sequencing costs, increasing genomics application areas, and the entry of new players and start-ups into the genomics business. However the high cost of genomic equipment in the coming years may, to a certain degree, restrict market development.
Get a Sample of this Report
Insulin Delivery System Market
